1 |
de Onis M, Blossner M, Borghi E. Global prevalence and trends of overweight and obesity among preschool children. Am J Clin Nutr 2010;92:1257-64.
DOI
|
2 |
Yildiz I, Erol OB, Toprak S, Cantez MS, Omer B, Kilic A, et al. Role of vitamin D in children with hepatosteatosis. J Pediatr Gastroenterol Nutr 2014;59:106-11.
DOI
|
3 |
Low S, Chin MC, Deurenberg-Yap M. Review on epidemic of obesity. Ann Acad Med Singap 2009;38:57-9.
|
4 |
Malespin M, Sleesman B, Lau A, Wong SS, Cotler SJ. Prevalence and correlates of suspected nonalcoholic fatty liver disease in Chinese American children. J Clin Gastroenterol 2015;49:345-9.
DOI
|
5 |
Burke A, Lucey MR. Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation. Am J Transplant 2004;4:686-93.
DOI
|
6 |
Di Sessa A, Umano GR, Cirillo G, Del Prete A, Iacomino R, Marzuillo P, et al. The membrane-bound O-Acyltransferase7 rs641738 variant in pediatric nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr 2018;67:69-74.
DOI
|
7 |
Khadaee GH, Saeidi M. Increases of obesity and overweight in children: an alarm for parents and policymakers. Int J Pediatr 2016;4:1591-601.
|
8 |
Walker RW. Genetic and dietary determinants of nonalcoholic fatty liver disease in Hispanic children [PhD dissertation]. Los Angeles: University of Southern California; 2013.
|
9 |
Della Corte C, Carpino G, De Vito R, De Stefanis C, Alisi A, Cianfarani S, et al. Docosahexanoic acid plus vitamin D treatment improves features of NAFLD in children with serum vitamin D deficiency: results from a single centre trial. PLoS One 2016;11:e0168216.
DOI
|
10 |
Papandreou D, Karabouta Z, Pantoleon A, Rousso I. Investigation of anthropometric, biochemical and dietary parameters of obese children with and without non-alcoholic fatty liver disease. Appetite 2012;59:939-44.
DOI
|
11 |
Trappoliere M, Tuccillo C, Federico A, Di Leva A, Niosi M, D'Alessio C, et al. The treatment of NAFLD. Eur Rev Med Pharmacol Sci 2005;9:299-304.
|
12 |
Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006;43(2 Suppl 1):S99-112.
DOI
|
13 |
Palomer X, Gonzalez-Clemente JM, Blanco-Vaca F, Mauricio D. Role of vitamin D in the pathogenesis of type 2 diabetes mellitus. Diabetes Obes Metab 2008;10:185-97.
DOI
|
14 |
Maki KC, Rubin MR, Wong LG, McManus JF, Jensen CD, Marshall JW, et al. Serum 25-hydroxyvitamin D is independently associated with high-density lipoprotein cholesterol and the metabolic syndrome in men and women. J Clin Lipidol 2009;3:289-96.
DOI
|
15 |
James WP. 22 Marabou symposium: the changing faces of vitamin D. Nutr Rev 2008;66(10 Suppl 2):S213-7.
DOI
|
16 |
Melamed ML, Michos ED, Post W, Astor B. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 2008;168:1629-37.
DOI
|
17 |
Foroughi M, Maghsoudi Z, Askari G. The effect of vitamin D supplementation on blood sugar and different indices of insulin resistance in patients with non-alcoholic fatty liver disease (NAFLD). Iran J Nurs Midwifery Res 2016;21:100-4.
DOI
|
18 |
Shiasi-Arani K, Ghasemi SE, Moravveji SA, Shahpouri-Arani A. Frequency of metabolic syndrome and type 2 diabetes among the obese children and adolescents in Kashan during 2009-11. Feyz J Kashan Univ Med Sci 2012;16:240-7.
|
19 |
Nobili V, Giorgio V, Liccardo D, Bedogni G, Morino G, Alisi A, et al. Vitamin D levels and liver histological alterations in children with nonalcoholic fatty liver disease. Eur J Endocrinol 2014;170:547-53.
DOI
|
20 |
Baziar N, DJafarian K, Shadman Z, Qorbani M, Khoshniat Nikoo M, Razi F. Effect of vitamin D supplementation on improving vitamin D levels and insulin resistance in vitamin D insufficient or defficient type2 diabetics. IJDLD 2014;13:425-33.
|
21 |
Han SS, Kim M, Kim H, Lee SM, Oh YJ, Lee JP, et al. Non-linear relationship between serum 25-hydroxyvitamin D and hemoglobin in Korean females: the Korean National Health and Nutrition Examination Survey 2010-2011. PLoS One 2013;8:e72605.
DOI
|
22 |
Sharma S, Jain R, Dabla PK. The role of 25-hydroxy vitamin D deficiency in iron deficient children of North India. Indian J Clin Biochem 2015;30:313-7.
DOI
|
23 |
Gagnon C, Lu ZX, Magliano DJ, Dunstan DW, Shaw JE, Zimmet PZ, et al. Low serum 25-hydroxyvitamin D is associated with increased risk of the development of the metabolic syndrome at five years: results from a national, population-based prospective study (The Australian Diabetes, Obesity and Lifestyle Study: AusDiab). J Clin Endocrinol Metab 2012;97:1953-61.
DOI
|
24 |
Takir M, Solak Y, Erek A, Kostek O, Oral A, Elcioglu OC, et al. Association between elevated serum uric acid and vitamin D insufficiency among the middle-aged and elderly population. Turk Nephrol Dial Transplant J 2016;25:182-6.
DOI
|
25 |
Peng H, Li H, Li C, Chao X, Zhang Q, Zhang Y. Association between vitamin D insufficiency and elevated serum uric acid among middle-aged and elderly Chinese Han women. PLoS One 2013;8:e61159.
DOI
|
26 |
Mohamed GA, Al-Harizi WM, Bedewi MA, Gafar HH. Vitamin D deficiency in knee osteoarthritis and its relationship with obesity in Saudi Arabia. Life Sci J 2015;12:104-11.
|
27 |
Kelishadi R, Salek S, Salek M, Hashemipour M, Movahedian M. Effects of vitamin D supplementation on insulin resistance and cardiometabolic risk factors in children with metabolic syndrome: a triple-masked controlled trial. J Pediatr (Rio J) 2014;90:28-34.
DOI
|
28 |
Ashraf AP, Alvarez JA, Gower BA, Saenz KH, McCormick KL. Associations of serum 25-hydroxyvitamin D and components of the metabolic syndrome in obese adolescent females. Obesity (Silver Spring) 2011;19:2214-21.
DOI
|
29 |
Rhee EJ, Kim MK, Park SE, Park CY, Baek KH, Lee WY, et al. High serum vitamin D levels reduce the risk for nonalcoholic fatty liver disease in healthy men independent of metabolic syndrome. Endocr J 2013;60:743-52.
DOI
|
30 |
Katz K, Brar PC, Parekh N, Liu YH, Weitzman M. Suspected nonalcoholic fatty liver disease is not associated with vitamin d status in adolescents after adjustment for obesity. J Obes 2010;2010:496829.
DOI
|
31 |
Amer M, Qayyum R. Relation between serum 25-hydroxyvitamin D and C-reactive protein in asymptomatic adults (from the continuous National Health and Nutrition Examination Survey 2001 to 2006). Am J Cardiol 2012;109:226-30.
DOI
|
32 |
Tavakoli F, Namakin K, Zardast M. Vitamin D supplementation and high-density lipoprotein cholesterol: a study in healthy school children. Iran J Pediatr 2016;26:e3311.
DOI
|
33 |
Ock SY, Ha KH, Kim BK, Kim HC, Shim JS, Lee MH, et al. Serum 25-hydroxyvitamin D concentration is independently inversely associated with insulin resistance in the healthy, non-obese Korean population. Diabetes Metab J 2016;40:367-75.
DOI
|
34 |
Song BM, Kim HC, Choi DP, Oh SM, Suh I. Association between serum 25-hydroxyvitamin D level and insulin resistance in a rural population. Yonsei Med J 2014;55:1036-41.
DOI
|
35 |
Choi DP, Oh SM, Lee JM, Cho HM, Lee WJ, Song BM, et al. Serum 25-hydroxyvitamin D and insulin resistance in apparently healthy adolescents. PLoS One 2014;9:e103108.
DOI
|
36 |
Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 2007;92:2017-29.
DOI
|